63 related articles for article (PubMed ID: 36891708)
1. [Strategies for hepatitis B virus-infected patients in the immune-tolerant phase: complete therapy at the last mile].
Ding Y; Sheng QJ; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):399-401. PubMed ID: 38858188
[TBL] [Abstract][Full Text] [Related]
2. [Research progress on clinical antiviral treatment of chronic hepatitis B in children].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):435-448. PubMed ID: 38858193
[TBL] [Abstract][Full Text] [Related]
3. Immune tolerant hepatitis B: a clinical dilemma.
Tran TT
Gastroenterol Hepatol (N Y); 2011 Aug; 7(8):511-6. PubMed ID: 22298987
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
[TBL] [Abstract][Full Text] [Related]
5. [Natural History and Treatment Indications of Chronic Hepatitis B].
Sinn DH
Korean J Gastroenterol; 2019 Nov; 74(5):245-250. PubMed ID: 31765552
[TBL] [Abstract][Full Text] [Related]
6. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
[No Abstract] [Full Text] [Related]
7. [Research progress on the characteristics of immune tolerant phase and antiviral therapy in children with chronic hepatitis B].
Li J; Fan PY; Hong WG; Zhang M; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1259-1265. PubMed ID: 36891708
[TBL] [Abstract][Full Text] [Related]
8. [New progress on the clinical study of antiviral therapy for chronic hepatitis B in children].
Fan PY; Li J; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):394-398. PubMed ID: 38858187
[TBL] [Abstract][Full Text] [Related]
9. Reasons to consider early treatment in chronic hepatitis B patients.
Koffas A; Petersen J; Kennedy PT
Antiviral Res; 2020 May; 177():104783. PubMed ID: 32217150
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
